SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023932
Filing Date
2023-07-07
Accepted
2023-07-07 11:15:11
Documents
14
Period of Report
2023-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44302
2 ex3-1.htm EX-3.1 56854
3 ex10-1.htm EX-10.1 38622
  Complete submission text file 0001493152-23-023932.txt   333684

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sigy-20230630.xsd EX-101.SCH 3042
5 XBRL LABEL FILE sigy-20230630_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE sigy-20230630_pre.xml EX-101.PRE 22377
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3237
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

IRS No.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 231075717
SIC: 3841 Surgical & Medical Instruments & Apparatus